Literature DB >> 36272980

Alarming antibiotics resistance of Helicobacter pylori from children in Southeast China over 6 years.

Xiaoli Shu1, Diya Ye1, Chenmin Hu1, Kerong Peng2, Hong Zhao2, Huamei Li1, Mizu Jiang3,4,5.   

Abstract

The increasing rates of antibiotic resistance in Helicobacter pylori (H. pylori) are a major concern of the decreasing eradication rate. Large-scale and long-period studies on antimicrobial susceptibility of H. pylori in children are limited. This study aimed to describe the temporal changes of antibiotic resistance among children in southeast China. Gastric biopsies obtained from children were cultured for H. pylori from 2015 to 2020. Susceptibility to clarithromycin (CLA), amoxicillin (AML), metronidazole (MTZ), furazolidone (FZD), tetracycline (TET) and levofloxacin (LEV) was tested. Data from 2012 to 2014 reported previously were obtained for comparing the change in temporal trends of antibiotic resistance. A total of 1638 (52.7%) H. pylori strains were isolated from 3111 children recruited. The resistance rates to CLA, MTZ and LEV were 32.8%, 81.7% and 22.8%, respectively. There were 52.9% strains resistant to single resistance, 28.7% to double resistance, and 9.0% to triple resistance. The total resistance rate and resistance rates to CLA, MTZ, LEV, CLA + LEV and CLA + MTZ + LEV increased annually in a linear manner. All resistant patterns except single resistance increased obviously from 2015 to 2017 and 2018 to 2020 compared to that from 2012 to 2014. Double resistance to CLA + MTZ increased significantly with age. The resistance rate to CLA and triple resistance to CLA, MTZ and LEV increased in children with prior H. pylori treatment than that from children without prior treatment. The antibiotic resistance rates of H. pylori were high in a large pediatric population in southeast China from 2015 to 2020. Individual treatment based on susceptibility test is imperative and optimal regimens should be chosen in H. pylori eradication therapy.
© 2022. The Author(s).

Entities:  

Year:  2022        PMID: 36272980     DOI: 10.1038/s41598-022-21661-y

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.996


  26 in total

1.  Comparison of primary and secondary antimicrobial minimum inhibitory concentrations for Helicobacter pylori isolated from Korean patients.

Authors:  Jung Mogg Kim; Joo Sung Kim; Nayoung Kim; Sang Gyun Kim; Hyun Chae Jung; In Sung Song
Journal:  Int J Antimicrob Agents       Date:  2006-06-05       Impact factor: 5.283

2.  The Toronto Helicobacter pylori Consensus in Context.

Authors:  Yaron Niv
Journal:  Gastroenterology       Date:  2016-11-27       Impact factor: 22.682

3.  Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.

Authors:  P Malfertheiner; F Megraud; C A O'Morain; J P Gisbert; E J Kuipers; A T Axon; F Bazzoli; A Gasbarrini; J Atherton; D Y Graham; R Hunt; P Moayyedi; T Rokkas; M Rugge; M Selgrad; S Suerbaum; K Sugano; E M El-Omar
Journal:  Gut       Date:  2016-10-05       Impact factor: 23.059

4.  Fifth Chinese National Consensus Report on the management of Helicobacter pylori infection.

Authors:  Wen Zhong Liu; Yong Xie; Hong Lu; Hong Cheng; Zhi Rong Zeng; Li Ya Zhou; Ye Chen; Jiang Bin Wang; Yi Qi Du; Nong Hua Lu
Journal:  Helicobacter       Date:  2018-03-07       Impact factor: 5.753

5.  Gastric cancer: evidence boosts Helicobacter pylori eradication.

Authors:  Hidekazu Suzuki; Juntaro Matsuzaki
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2018-08       Impact factor: 46.802

6.  Antibiotics resistance of Helicobacter pylori in children with upper gastrointestinal symptoms in Hangzhou, China.

Authors:  Xiaoli Shu; Guofeng Yin; Mingnan Liu; Kerong Peng; Hong Zhao; Mizu Jiang
Journal:  Helicobacter       Date:  2018-03-12       Impact factor: 5.753

7.  Joint ESPGHAN/NASPGHAN Guidelines for the Management of Helicobacter pylori in Children and Adolescents (Update 2016).

Authors:  Nicola L Jones; Sibylle Koletzko; Karen Goodman; Patrick Bontems; Samy Cadranel; Thomas Casswall; Steve Czinn; Benjamin D Gold; Jeannette Guarner; Yoram Elitsur; Matjaž Homan; Nicolas Kalach; Michal Kori; Armando Madrazo; Francis Megraud; Alexandra Papadopoulou; Marion Rowland
Journal:  J Pediatr Gastroenterol Nutr       Date:  2017-06       Impact factor: 2.839

Review 8.  Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis.

Authors:  James K Y Hooi; Wan Ying Lai; Wee Khoon Ng; Michael M Y Suen; Fox E Underwood; Divine Tanyingoh; Peter Malfertheiner; David Y Graham; Vincent W S Wong; Justin C Y Wu; Francis K L Chan; Joseph J Y Sung; Gilaad G Kaplan; Siew C Ng
Journal:  Gastroenterology       Date:  2017-04-27       Impact factor: 22.682

9.  Consensus on eradication of Helicobacter pylori and prevention and control of gastric cancer in China (2019, Shanghai).

Authors:  Yiqi Du; Huiyun Zhu; Jiong Liu; Jingnan Li; Xin Chang; Liya Zhou; Minhu Chen; Nonghua Lu; Zhaoshen Li
Journal:  J Gastroenterol Hepatol       Date:  2020-01-24       Impact factor: 4.029

10.  The updated JSPGHAN guidelines for the management of Helicobacter pylori infection in childhood.

Authors:  Seiichi Kato; Toshiaki Shimizu; Shigeru Toyoda; Benjamin D Gold; Shinobu Ida; Takashi Ishige; Shigeru Fujimura; Shigeru Kamiya; Mutsuko Konno; Kentaro Kuwabara; Kosuke Ushijima; Norikazu Yoshimura; Yoshiko Nakayama
Journal:  Pediatr Int       Date:  2020-12       Impact factor: 1.524

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.